ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
This Quarter Return
+51.92%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$259M
AUM Growth
+$259M
(+25%)
Cap. Flow
+$8.96M
Cap. Flow
% of AUM
3.45%
Top 10 Holdings %
Top 10 Hldgs %
66.68%
Holding
41
New
8
Increased
13
Reduced
5
Closed
12
Top Buys
| 1 |
Axsome Therapeutics
AXSM
|
$11.3M |
| 2 |
Milestone Pharmaceuticals
MIST
|
$9.42M |
| 3 |
ATNX
Athenex, Inc. Common Stock
ATNX
|
$9.36M |
| 4 |
Arrowhead Research
ARWR
|
$8.24M |
| 5 |
Aurinia Pharmaceuticals
AUPH
|
$6.15M |
Top Sells
| 1 |
CASM
CAS Medical Systems, Inc.
CASM
|
$12.8M |
| 2 |
Iovance Biotherapeutics
IOVA
|
$12.7M |
| 3 |
DERM
Dermira, Inc.
DERM
|
$8.63M |
| 4 |
Assembly Biosciences
ASMB
|
$8.13M |
| 5 |
CBAY
Cymabay Therapeutics
CBAY
|
$6.87M |
Sector Composition
| 1 | Healthcare | 93.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Iovance Biotherapeutics
IOVA
$807M
| $59.5M | 21.16% | 2,426,701 -517,500 | -18% | -$12.7M |
|
|
KDMN
2
DELISTED
Kadmon Holdings, Inc.
KDMN
| $15.7M | 5.58% | 7,617,500 -17,500 | -0.2% | -$36.1K |
|
3
Adverum Biotechnologies
ADVM
$64.6M
| $14.1M | 5.03% | 1,190,000 +271,000 | +29% | +$3.22M |
|
4
Veracyte
VCYT
$2.39B
| $13.7M | 4.88% | 481,500 +100,000 | +26% | +$2.85M |
|
|
5
Arrowhead Research
ARWR
$3.05B
| $12.7M | 4.51% | 478,500 +311,000 | +186% | +$8.24M |
|
6
Arvinas
ARVN
$568M
| $12.1M | 4.31% | 551,000 +237,000 | +75% | +$5.21M |
|
7
argenx
ARGX
$43.6B
| $11.5M | 4.08% | 81,000 +17,500 | +28% | +$2.48M |
|
|
8
Axsome Therapeutics
AXSM
$6.05B
| $11.3M | 4.01% | +437,500 | New | +$11.3M |
|
|
BHVN
9
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $11.2M | 3.97% | 255,000 +49,000 | +24% | +$2.15M |
|
10
Insmed
INSM
$28.8B
| $11.1M | 3.96% | 435,500 +65,500 | +18% | +$1.68M |
|
|
11
Milestone Pharmaceuticals
MIST
$156M
| $9.42M | 3.35% | +347,000 | New | +$9.42M |
|
|
ATNX
12
DELISTED
Athenex, Inc. Common Stock
ATNX
| $9.36M | 3.33% | +472,500 | New | +$9.36M |
|
13
Protagonist Therapeutics
PTGX
$3.67B
| $8.13M | 2.89% | 671,500 +334,000 | +99% | +$4.04M |
|
|
VRAY
14
DELISTED
ViewRay, Inc.
VRAY
| $7.42M | 2.64% | 842,500 +27,500 | +3% | +$242K |
|
15
Xenon Pharmaceuticals
XENE
$2.98B
| $6.92M | 2.46% | 701,500 +149,000 | +27% | +$1.47M |
|
|
MRTX
16
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $6.44M | 2.29% | 62,500 +21,500 | +52% | +$2.21M |
|
|
17
Aurinia Pharmaceuticals
AUPH
$1.58B
| $6.15M | 2.19% | +935,000 | New | +$6.15M |
|
|
DRNA
18
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $6.06M | 2.15% | 384,500 +55,675 | +17% | +$877K |
|
19
IRIDEX
IRIX
$22.8M
| $5.33M | 1.89% | 1,171,300 -3,200 | -0.3% | -$14.6K |
|
20
KalVista Pharmaceuticals
KALV
$678M
| $4.72M | 1.68% | 213,000 +7,500 | +4% | +$166K |
|
21
Amicus Therapeutics
FOLD
$2.34B
| $4.37M | 1.55% | +350,000 | New | +$4.37M |
|
22
CRISPR Therapeutics
CRSP
$4.71B
| $3.72M | 1.32% | +79,000 | New | +$3.72M |
|
|
IMMU
23
DELISTED
Immunomedics Inc
IMMU
| $3.12M | 1.11% | 225,000 -275,000 | -55% | -$3.81M |
|
|
24
Assembly Biosciences
ASMB
$190M
| $2.13M | 0.76% | 158,000 -602,500 | -79% | -$8.13M |
|
25
Danaher
DHR
$147B
| $1.64M | 0.58% | +11,500 | New | +$1.64M |
|